Tag: philips
Philips launches new motorised mobile C-arm system
Royal Philips has announced the launch of their image-guided therapy mobile C-arm system 9000—Zenition 90 Motorized, designed to help surgeons deliver high-quality care to...
Philips launches Azurion neuro biplane system
Royal Philips has announced major enhancements to its image guided therapy system—Azurion—with the launch of its new Azurion neuro biplane system.
Featuring enhanced imaging and...
Vein360 receives US FDA clearance to reprocess the Philips Visions PV...
Vein360 has announced it received US Food and Drug Administration (FDA) 510(k) clearance for reprocessing the Philips Visions PV 0.035 digital intravascular ultrasound (IVUS)...
Vascular News’ top 10 most popular stories of April 2023
April's top 10 sees a product announcement from Terumo Aortic take the top spot, with highlights from the 2023 Charing Cross (CX) International Symposium...
Fibre optic technology shows “transformative” potential in endovascular aortic procedures
This advertorial is sponsored by Philips.
Two early adopters of Fiber Optic RealShape (FORS; Philips) share their expert opinions on the developing technology, highlighting its...
Northeast Scientific awarded 510(k) clearance to reprocess the Eagle Eye Platinum...
Northeast Scientific announced this week it has received US Food and Drug Administration (FDA) 510(k) clearance for reprocessing the intravascular ultrasound (IVUS) Eagle Eye...
Vascular News’ top 10 most popular stories of August 2022
The establishment of the first-ever global consensus for the appropriate use of intravascular ultrasound (IVUS) in lower extremity and arterial and venous interventions, results...
Safer imaging technology for complex aortic repairs uses light instead of...
A new imaging device at University of Texas (UT) Southwestern (Dallas, USA) is making complex aortic repairs safer for patients and operating room staff...
Vascular experts establish appropriate use of IVUS in peripheral interventions
Royal Philips today announced an important milestone in the evolving standard of care for treating patients with peripheral vascular disease: the establishment of the...
Philips announces positive three-year clinical research results from its TOBA II...
Royal Philips today announced the latest results from the Tack optimised balloon angioplasty (TOBA) II below-the-knee (BTK) clinical trial, demonstrating that the Philips endovascular...
Revascularisation strategy for BTK intervention should hinge on diagnostic modality, LINC...
New data provide “another argument” for the use of intravascular ultrasound (IVUS) in below-the-knee (BTK) interventions. This is according to Michael Lichtenberg (Arnsberg Vascular...
Philips integrates cloud-based AI and 3D mapping into its mobile C-arm...
Royal Philips today announced physicians will now have access to advanced new 3D image guidance capabilities through its image-guided therapy mobile C-arm system—Zenition. The...
Vascular News’ top 10 most popular stories of November 2021
November's top 10 features a large-scale analysis of Philips' intravascular ultrasound (IVUS) in lower extremity peripheral vascular interventions, five-year data on Avenu Medical/Medtronic's Ellipsys...
Large-scale IVUS analysis adds “meaningful data” to growing pool of evidence
A large-scale analysis of the use of Philips' intravascular ultrasound (IVUS) in lower extremity peripheral vascular interventions adds “meaningful data” to a growing pool...
Philips IVUS linked with improved health outcomes in large-scale analysis of...
Royal Philips today announced the results of a new large-scale, real-world analysis of Centers for Medicare & Medicaid Services (CMS) data on the health...
VIVA 2021: Consensus established for appropriate use of IVUS in peripheral...
A worldwide committee of 40 cross-speciality medical experts achieved the first-ever consensus for the appropriate use of intravascular ultrasound (IVUS) in peripheral vascular disease...
Vascular News’ top 10 most popular stories of June 2021
New data from Philips' TOBA II below-the-knee (BTK) clinical trial, physicians' call for the AMPREDICT decision support tool to be applied in clinical practice,...
Philips announces positive two-year data from TOBA II BTK clinical trial
Royal Philips recently announced positive two-year results from the TOBA (Tack optimised balloon angioplasty) II below-the-knee (BTK) clinical trial.
The data show the Philips...
How Fiber Optic RealShape (FORS) technology provides 3D device guidance using...
Tilo Kölbel (Hamburg, Germany; moderator) is joined by Geert Willem Schurink (Maastricht, Netherlands) and Joost van Herwaarden (Utrecht, Netherlands) in this Vascular News roundtable,...
Vascular News’ top 10 most popular stories of April 2021
Highlights from the Charing Cross (CX) 2021 Digital Edition (19–22 April, online)—including the potential of Philips’ Fiber Optic RealShape (FORS) technology to reduce radiation...
Philips SmartCT application software receives FDA 510(k) clearance
Royal Philips today announced US Food and Drug Administration (FDA) 510(k) clearance for its Philips SmartCT application software. SmartCT is a key component of...
Philips introduces 3D ultrasound-based model for AAA surveillance
Royal Philips has introduced the Philips Abdominal Aortic Aneurysm (AAA) Model, providing physicians a more patient-friendly solution compared to the current standard of care for...
LINC 2021: Five-year ILLUMENATE results confirm safety profile of Philips Stellarex...
Royal Philips has announced the final, five-year results of two randomised controlled trials (RCTs) that show no difference in all-cause mortality between patients treated...
Philips launches QuickClear mechanical thrombectomy system for blood clot removal in...
Royal Philips has announced the launch of the QuickClear mechanical thrombectomy system. The single-use system delivers an all-in-one aspiration pump and catheter to remove...
The value of IVUS in endovascular procedures
In this supplement, sponsored by Philips:
Paul Gagne explains how intravascular ultrasound (IVUS) can be used to guide the treatment of chronic venous disease,...
Philips to expand its image-guided therapy portfolio through acquisition of Intact...
Royal Philips today announced that it has signed an agreement to acquire Intact Vascular. According to a press release, Intact Vascular will enhance Philips’...
New data reconfirm long-term safety profile of the Philips Stellarex low-dose...
Royal Philips recently announced the four-year results from the ILLUMENATE European randomised controlled trial (EU RCT). The Stellarex drug-coated balloon (DCB) cohort demonstrated similar...
Philips and the US government collaborate in ventilator production ramp up...
Royal Philips has announced that the US government and Philips agreed to team up to increase the production of hospital ventilators in its manufacturing...
Philips and the US government collaborate in ventilator production ramp up...
Royal Philips has announced that the US government and Philips agreed to team up to increase the production of hospital ventilators in its manufacturing...
New developments in intraoperative navigation show “revolutionary” potential
The early months of 2020 have seen the emergence of new technologies in the intraoperative navigation space. Here, Vascular News considers Philips’ Fiber Optic...
LINC 2020: Four-year ILLUMENATE data reaffirm safety profile of Stellarex
Philips today announced four-year results from the randomised controlled ILLUMENATE pivotal trial in the USA. The data show similar mortality rates through four years...
VEITH 2019: Fiber Optic RealShape (FORS) technology could spark a new...
Joost van Herwaarden (Utrecht, The Netherlands) and Tilo Kölbel (Hamburg, Germany) discuss the current challenges of image-guided therapy—primarily regarding the limiting factor of having...
Philips receives FDA approval for low-dose drug-coated balloons
Philips has received US Food and Drug Administration (FDA) approval for two Stellarex 0.035” low-dose (200mm and 150mm) drug-coated balloons for the treatment of...
Late-breaking ILLUMENATE data demonstrate three-year safety and efficacy for Stellarex DCB
Three-year results from the ILLUMENATE Pivotal trial and the ILLUMENATE European randomised controlled trial (EU RCT) have been presented in a late-breaking trial session...
Augmented reality surgical technology unveiled by Philips and Microsoft
At the MWC (25–26 February, Barcelona, Spain), formerly the Mobile World Congress, Philips unveiled a unique mixed reality concept developed in partnership with Microsoft for...
Philips launches Zenition mobile C-arm platform
Philips Zenition, a new mobile C-arm imaging platform from Philips, has launched in the USA, Germany, Austria and Switzerland. It is being introduced into...
New data release at LINC 2019 reinforces safety profile of low-dose...
Sean Lyden (Cleveland, USA) and Fabrizio Fanelli (Rome, Italy) discuss the safety and future of drug-coated balloons (DCB) in light of the latest pooled...
Philips launces Azurion with FlexArm to aid image-guided procedures
Philips launches its Azurion with FlexArm to aid patient imaging and positioning during image-guided procedures.
During increasingly complex interventions, clinicians need to quickly and easily...
Philips launches Azurion with FlexArm to aid image-guided procedures
Philips launches its Azurion with FlexArm platform to aid patient imaging and positioning during image-guided procedures.
Azurion with FlexArm allows clinicians to intraoperatively visualise patient...
First US patient enrolled in ILLUMENATE BTK study of Stellarex 0.014...
The first US patient has been enrolled in the Stellarex ILLUMENATE below-the-knee (BTK) investigational device exemption (IDE) study, led by principal investigators Bill Gray...
Similar patency outcomes in women and men treated with Stellarex DCB
A study presented at VIVA 2018 (5–8 November, Las Vegas, USA) by Maureen Kohi, associate professor of Clinical Radiology, University of California, San Francisco,...
Image-guided therapy platform benefits clinical workflow and staff experience
Philips has announced the results of an independent two-year study on clinicians' use of Azurion, the company's image-guided therapy platform, at St. Antonius Hospital....
Merging the portfolios and strengths of Philips and Spectranetics
At the recent Vascular Interventional Advances 2017 conference (VIVA; 11–14 September, Las Vegas, USA), Vascular News caught up with Philips' Atul Gupta (Global Chief...
Two-year efficacy of Philips’ Stellarex 0.035” low-dose drug-coated balloon demonstrated
Philips has announced the two-year results from the ILLUMENATE European randomised clinical trial (EU RCT) demonstrating the efficacy of the Philips Spectranetics’ Stellarex 0.035”...
Philips completes acquisition of Spectranetics
Philips has completed the acquisition of Spectranetics. Spectranetics’ financial results will be consolidated as part of Philips’ Image-Guided Therapy business group as of August...
Philips acquires CardioProlific
Royal Philips has announced the acquisition of CardioProlific Inc, a USA-based, privately-held company that is developing catheter-based thrombectomy approaches to treat peripheral vascular disease. Financial...
Philips to acquire Spectranetics
Royal Philips and The Spectranetics Corporation have entered into a definitive merger agreement. Pursuant to the agreement, Philips will commence a tender offer to acquire all of...
Philips announces the relaunch of the Pioneer Plus catheter
Philips has announced the relaunch of its Pioneer Plus catheter, “the first and only re-entry device with intravascular ultrasound (IVUS) capabilities and needle deployment designed...
Philips launches Azurion worldwide
Philips has announced the global launch of Azurion, its next generation image-guided therapy platform that integrates advanced interventional tools into one clinician platform. Azurion...
Improving patient outcomes in today’s cost-controlled health systems
Atul Gupta, MD, Interventional Radiologist and Chief Medical Officer, Philips Image Guided Therapy
Our roles as interventionalists have been transformed over the past 20 years....
